Related Experiment Video

Updated: Aug 16, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

Infectious risk in pediatric organ transplant recipients: is it increased with the new immunosuppressive agents?

Edith Renoult1, Chantal Buteau, Valérie Lamarre

  • 1Infectious Diseases Division, Department of Pediatrics, Hopital Sainte-Justine, University of Montreal, Montreal, Quebec, Canada. erenoult@msn.edu

Pediatric Transplantation
|July 29, 2005
PubMed

Insights

Pediatric organ transplant recipients face infection risks influenced by age, transplant type, and evolving immunosuppressive treatments. This review details current immunosuppression, associated infections, and strategies to mitigate risks in children.

Area of Science:

  • Pediatric medicine
  • Transplantation immunology
  • Infectious diseases

Background:

  • Infection risk in pediatric organ transplant recipients is multifactorial.
  • Current immunosuppressive protocols and their infectious complications require further investigation.
  • Significant changes in immunosuppressive treatments over the last decade necessitate updated understanding.

Purpose of the Study:

  • To review current immunosuppressive agents, their mechanisms, and new regimens in pediatric organ transplantation.
  • To analyze infectious complications linked to immunosuppression, including adverse reactions.
  • To propose strategies for minimizing infection risk in pediatric transplant patients on novel immunosuppressive therapies.

Main Methods:

  • Literature review of immunosuppressive agents and their impact on infections.
  • Analysis of infectious complications associated with current immunosuppressive protocols.
  • Synthesis of data on anti-infectious properties and adverse reactions of immunosuppressants.

Main Results:

  • Detailed examination of immunosuppressive agents, focusing on novel regimens and mechanisms of action.
  • Identification of infections arising from excessive immunosuppression.
  • Evaluation of specific immunosuppressive agents for anti-infectious properties and infectious adverse reactions.

Conclusions:

  • Current immunosuppressive protocols present unique infection risks in pediatric organ transplant recipients.
  • Advances in monitoring, diagnostics, and prophylaxis are crucial for managing infections.
  • Proposed strategies aim to minimize infection risk associated with immunosuppressive therapy in this vulnerable population.

More Related Videos

Murine Full-thickness Skin Transplantation07:59

Murine Full-thickness Skin Transplantation

Published on: January 2, 2017

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...